Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stanley Kandzari

Urology Morgantown, WV Medical Doctor

NPI 1972697589 CMS profile 89220

1 Stadium Drive, Morgantown, WV 26506

Open in the dashboard

General payments

$4,645

130 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stanley Kandzari of Morgantown, WV is reported in the CMS Open Payments database as having received $4,645 across 130 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $227 3
2024 General $617 12
2023 General $1,103 24
2022 General $1,081 24
2021 General $795 26
2020 General $316 16
2019 General $506 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stanley Kandzari
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Stanley Kandzari were reported at $227. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Stanley Kandzari Urology median Middle half National median
2019 $506 $480 $147–$1,201 $163
2020 $316 $246 $87–$645 $114
2021 $795 $358 $111–$1,000 $132
2022 $1,081 $476 $143–$1,263 $149
2023 $1,103 $560 $168–$1,461 $160
2024 $617 $563 $170–$1,464 $164
2025 $227 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $2,539 93 payments
  2. Axonics Modulation Technologies, Inc. $442 6 payments
  3. Medtronic, Inc. $276 11 payments
  4. Sumitomo Pharma America, Inc. $206 2 payments
  5. Coloplast Corp $174 2 payments
  6. Olympus America Inc. $155 2 payments
  7. Davol Inc. $122 1 payment
  8. Bard Access Systems, Inc. $109 1 payment
  9. Teleflex LLC $108 1 payment
  10. Ambu Inc. $94 1 payment
  11. Other $420 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,645 130 payments
Products named General payments · program years 2019–2025
  1. LithoVue LithoVue_URO $824 20 payments
  2. LITHOVUE Scope $306 20 payments
  3. INTERSTIM $276 11 payments
  4. Bulkamid $212 3 payments
  5. Titan $174 2 payments
  6. iTIND System $155 2 payments
  7. Axonics $143 2 payments
  8. LITHOVUE Lithovue $136 2 payments
  9. ARISTA AH FlexiTip $122 1 payment
  10. LITHOVUE Pain Management $119 6 payments
  11. Other $1,935 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$4,530

Medicare's payments for the services billed

Medicare patients

22

Average age 71

Services billed

38

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 55%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

130 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record